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Abstract. In screening cytotoxic agents in morphine alkaloids 
fTE1-IOJ, codeinone fTE8J was cytotoxic against two human 
oral tumor cells lines (HSC-2 and HSG). The cytotoxic activity 
of codeinone (CC50=1.0-1.2 pglmL) against HSC-2 or HSG 
cells was higher than that of doxorubicin (CC50=1.9-2.0 
/lg/mL). Human oral gingival fibroblasts (HGF) were relatively 
resistant to codeinone, as judged by higher SI ratio (3. 7) 
suggesting the tumor-selective cytotoxicty of codeinone. The 
cytotoxic activity of morphine (CC50=221 /4glmL) against HSC-
2 was slightly lower than that of codeine (CC50=186 /lg/mL), 
thebaine (CC50 = 125 /4g/mL), etorphine (CC50 = 94 14glmL) or 
dihydroetorphine (CC50=60 Ilg/mL). A study of structurally-
related compounds su8gested that the a,p-unsaturated ketone 
group of codeinone was responsible for its antitumor cytotoxicity. 
The cytotoxic activity of codeinone was si8nlficantly reduced by 
N-acetylcysteine, but not affected by FeC13~ CuC1~ CoC12~ 
sodium ascorbate or catalase. Neither codeinone nor morphine 
inhibited P-glycoproteinimediated rhodamine-123 efflux in 
multidrug resistant mouse T Iymphoma L5178 transfected with 
human MDR I gene. These data sugg;est that codeinone induces 
cytotoxicity in oral tumor cell lines, possibly by a Michael-like 
addition of a protein SH or of an amino 8Toup to the bouble 
bond of codeinone. 
The morphine alkaloids are an important group of pharma-
ceuticals which have powerful analgesic properties. Recently, 
it has been shown that some opiates, such as morphine (1-3), 
etorphine (4) and buprenorphine (5, 6) are able to induce 
apoptosis in several cell lines. It is interesting that morphine 
has anticancer activity in vitro (2, 7). We were prompted to 
evaluate a series of morphine alkaloids for their antitumor 
cytotoxicity and here report our findings. Furthermore, we 
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studied the MDR modulating activity of these morphine 
alkal ids on mouse lymhoma cells transfected with MDR 1 
gene, because an interact on of morphine and P-glycoprotein 
(Pgp has been previously reported (8). 
Materials and M thods 
Chemicals. The follow g chemicals were obtained from each indicated 
company: (:t)-verapamil (Aldrich, Milwarkee, Wisconsin, USA); RPMI 
1640 medium (GIBCo, Grand Island, NY, USA); ascorbic acid (Tokyo 
Kasei Kogyo Co. Ltd., Japan); fetal bovine serum (FBS) (JRH Biosci., 
Lenexa, KS, USA). Morphine hydrochloride [TEIO] was purchased from 
Takeda Pharmaceutical Industries Co., Ltd. (Osaka, Japan). Codeinone 
[TE8] w s synthesized from codeine [TE7] according to the literature 
(9). The compounds [TE1-6 and 9] were prepared from codeine [TE7] 
using previously documented procedures (10, 11). 
Cell culture. Human promyelocytic leukemia (HL-60) cells were mainta;i-
ned at 37'C in RPMI 1640 medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (JRH Biosciences, Lenexa, KS, 
U.S.A.) in a humidified 5% C02 atmosphere. Human squamous cell 
carcinoma (HSC-2) cells and human salivary gland tumor (HSG) cells 
were maintained as monolayer cultures at 37'C in Dulbecco's modified 
Eagle medium (DMEM) (Gibco BRL, Grand Island, NY, U.S.A.) 
supplemented with 10% heat-inactivated FBS in a humidified 5% C02 
atmosphere, then subcultured by trypsinization. Human gingival fibro-
blasts (HGF) were isolated from healthy gingival biopsies of a 10-year-
old female, as described previously (12). Cells between the fifth and 
seventh passages were used. 
Cytotoxic activity. T e cells were incubated for 24 hours with the indi-
cated concentrations of test samples in culture medium and the viable 
cell number was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) method (12). 
Assay for DNA fragmentation. The cells were lysed with 50 uL Iysis buffer 
[50 mM Tris-HC1, pH 7.8, 10 mM EDTA, 0.5% (w/v) sodium 
N-lauroylsarcosinate]. The solution was incubated sequentially with 4 
mg/mL RNase A for 60 minutes at 50'C and 4 mg/mL proteinase K for 
60 minutes at 50'C. DNA was extracted and precipitated by 70% 
ethanol, then dissolved in TE buffer (10 mM Tris-HCl, pH 7.4, I mM 
EDTA, pH 8.0). DNA, equivalent to 5 x l06 cells, was applied to 1.8% 
agarose gel electrophoresis. The DNA fragmentation pattern was 
examined in photographs taken under UV illumination. 
Cell and fluorescence uptake. MDR1/A expressing cell lines were selected 
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Table I. Cytotoxic activity of morphine alkaloids against tumor and normal 
cells. 
T ble II. Effect  of additives n the cytotoxicity of codeinone (TE8) against 
HSC-2 cells. 
Compound Cytotoxic activity (CC50, ug/mL) Additive Cytotoxic activity (CC50, ug/mL) 
HSG HGF 
(HGF/HSC-2) 
TE 1 
TE2 
TE3 
TE4 
TE5 
TE 6 
TE7 
TE8 
TE9 
TEIO 
1 25 
1 25 
,140 
120 
60 
94 
186 
1.0 
213 
22 1 
93 
156 
170 
115 
98 
63 
68 
1.2 
98 
170 
181 
178 
> 250 
>250 
188 
149 
218 
3.7 
> 250 
>250 
1.5 
1.4 
>1.8 
> 2. 1 
3.1 
1:6 
1.2 
3.7 
> 1.2 
>1.1 
none 
+ N-acetyl-L-cysteine (4 mM) 
+ L-cysteine (4 mM) 
+ sodium ascorbate (0.25 mM) 
+ catalase (3000 U/mL) 
+ FeC13 (0.2 mM) 
+ CoC12 (0.2 mM) 
+ CuC12 (0.2 mM) 
1.5 
49.46 
5.40 
1.29
1.02 
1.72 
1.55 
1.13 
HSC-2: Human oral squamous cell carcinoma cell line. 
Table 111. Effects of morphine alkaloids on the multidrug resistance of L-
51 78 cells. 
( :!: )-Verapamil 
Doxorubicin ' HCl 
51
2.0 
28 
1.9 
43 
> 10 
0.8 
>5.0 
Compounds Concentration FSCa SSCa FL-1a Fluorescence 
(ug/mL) activity ratio 
HSC-2: Human oral sqtiamous cell carcinoma cell line. 
HSG: Human oral salivary gland tumor cell line. 
HGF: Human oral gingival fibyoblasts (5-7 population doubling levels). 
by culturing the infected cells with 60 ng/mL colchicine to maintain the 
expiession of the MDR phenotype (13). The L5178 MDR celi line and 
the L5 178 Y parent cell line were grown in McCoy's 5A medium 
supplemented with 10% heat-inactivated horse serum, L-gluta6mine and 
antibiotics. The cells were adjusted to a density of 2 x 10 /mL and 
resuspended in serum-free McCoy's 5A medium, then a 0.5 mL aliquot 
of the cell sus~ension were distributed into each Eppendorf centrifuge 
tube. Next, 2 uL of 2 mg/mL test compounds were added and incubated 
for 10 minutes at room temperature. Subsequently, 50 uL rhodamine 123 
(R123) as an indicator was added to the samples (5.2 uM final 
concentration) and the cells were incubated for a further 20 minutes at 
37'C, washed twice and resuspended in 0.5 mL phosphate-buffered 
saline (PBS) (pH 7.4) for analysis. The fluorescence of the cell 
population was measured by flow cytometry using the Beckton 
Dickinson FACScan instrument (cell sorter). ( d: )-Verapamil (VP) was 
used as the positive control in R123 accumulation experiments (14). The 
R123 accumulation was calculated from the fluorescence of one height 
value using the equation y=10X/256. In the case of logarithmic 
transformation8~ the 1024 digital channels were switched to one decade at 
each 256 ( =2 ) channels. Then, the percentage of mean fluorescence 
intensity was calculated in the parental and MDR cell lines, compared to 
the untreated cells. The fluorescence activity ratio was calculated by the 
following equation (14, 15): 
Par (contro )b 
MDR + R123 (mean)' 
( ~ )-Verapamil 
TE 1 
TE2 
TE3 
TE4 
TE5 
TE6 
TE7 
TE8 
TE9
TEIO 
?
?
?
?
?
?
?
?
?
?
?
484 
582.5
5 24 
530 
509 
472 
44 1 
490 
467 
519 
493 
539 
53 1 
260.5 
193.5 
245 
287 
266 
23 5 
227 
225 
23 5 
220 
240 
225 
23 O 
6068 
140.5 
654 
229 
1 24 
132 
1 24 
1 87 
1 80 
128 
1 87 
136 
141 
43.3 
4.7 
1.6 
0.9 
0.9
0.9 
1.3 
1.3 
0.9 
1.3
1.0 
1.0 
MDR revarsal activity = (MDR treated/MDR control)/(parental treated/ 
parental control) 
Results and Discussion 
Cytotoxic activity. This study was designed to compare the 
cytotoxicity of several structurally-related opiate alkaloids 
aFSC: Forward scatter count; SSC: Side scatter count; FL-1: Fluorescence. 
bpar: a perental cell without MDR gene. 
CMDR: a pa ntal cell transfected with MDR gene. 
(Figure 1) in human oral squamous cell carcinoma cell (HSC-
2) Iine, human oral salivary gland tumor cell (HSG) Iine and 
human oral gingival fibroblasts (HGF). The opiates showed 
significantly varied cyiotoxicity, depending on the structural 
features. As shown in Table I, the cytotoxic activity of these 
opiates against HSC-2 cells was: codeinone [TE8] (CC50= 1.0 
ug/mL) > dihydroetorphine [TE5] (CC50=60 u~mL) > 
etorphine [TE6] (CC50=94 ugimL) > thebaine [TEl] 
(CC50=125 ugimL) > codeine [TE7] (CC50=186 ug/mL) > 
morphine [TEIO] (CC50=221 ug/mL). The cytotoxic activity 
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Figure 1. Chemical structure of morphine alkaloids. 
of codeinone [TE8] (CC50=1.0-1.2 ug/mL) against HSC-2 or 
HSG cells was higher than that of doxorubicine (CC50=1.9-
2.0 ug/mL). Normal fibroblasts (HGF) were relatively 
resistant to codeinone [TE8], as judged by higher SI ratio 
(3.7), suggesting the tumor-selective cytotoxicity of codeinone 
[TE8]. These selective actions add to their antitumor 
potential. 
Codeinone is formed by the metabolism of codeine and is 
about thirty times more toxic than codeine (16). Glutathione 
(GSH) acts as a scavenger of codeinone (17). This is due to 
the fact that codeinone rapidly reacted in vitro with GSH, 
probably at the C-8 position by Michael addition, whereas 
codeine does not react with GSH (18). To clarify the mode of 
cell death induction by codeinone, the effect of codeinone on 
the internucleosomal DNA fragmentation characteristic of 
apoptosis was studied. Codeinone (4-8 ug/mL) elicited 
internucleosomal DNA cleavage, as shown by the agarose gel 
electrophores s of DNA extracted from the treated HL-60 
cells (Figure 2) . A higher dose failed to induce DNA 
fragmentation, suggesting the presence of an optimal 
concentration for the induction of DNA fragmentation 
(Figure 2) . 
The effects of inhib ors on codeinone-induced cell death 
were also studied. The cyiotoxic activity of codeinone was 
significantly reduc d by N-acetylcysteine, but not affected by 
FeC13, CuC12, CoC12, sodium ascorbate or catalase (Table II). 
Reversal of multidrug resistance (MDR) on tumor cells. MDR 
cells express he membrane glycoprotein (170 kDa) known as 
Pgp, which is an ATP-dependent active efflux pump. It has 
been demonstrated that the transport of morphine across the 
blood-brain b rier (BBB) is affected by Pgp both in vitro and 
in vivo (8). We measured the ability of opiates to inhibit Pgp-
mediated R123 efflux in the MDR mouse T cell lymphoma 
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Fi~ur~ ~ 
6 hours TE8 (ug/mL) 12 hours TE8 (ug/*L) 
Uv 16 uv o 1 2 4 8 16 
l ~f!'T'-Y(' ,~('! ,v,,f!ih:'i,, r~r Dj~=.J Jirr~"tt'!'rtr'if"t ({f H!.r~r, ~,'!!.T ~'T'~t"f " ' I Iht  !"t!s(',1(t' (' ,t'tk'f,,v"~ f I'-S, 
L5178 trEm~_1*ecled with hum~in IVfDR I ~*ene ~vhich ~l'as 
cL]]tureL] In co]chlcine-containing mediLml (Table 111) 
Addition of (:i:)-verapami] reversed the MDR, as reflected bv 
the incrc~lse [n Ri23 accLLmulation (lluorescence actlvit}' r2rtio 
(FR)=4.7) (Table 111) Table 111 shows that most of the 
morphine alktlloids [TEl-lO] falled to reverse MDR 
(FR=0 9-1 7), compilred tO. higher MDR reversing ~ctivity of 
(:!:)-verap~lrnil 
Thc present study demonstraled lhal the c}'totoxic ~Lctivity 
of the opiates was more pranounced tumor cell lines (HSC-2, 
HSG), ~LS co]1lpared to against norma] fibroblasts (HGF) The 
most potcnt codcinone had an (i,1~-LLnsatLlrated carbanyi 
group, which m[_~ht contribute as a Michael acceptor in thc 
structL]ro Thus* codeinone could affer an interesting mode! 
fo.r tl]e design of new compounds endowed with antitumor 
cytotoxicity 
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